Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group ,2022
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group ,2022
Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study ,2023
Diffusion-weighted MRI of metastatic brain tumors: relation of diffusion parameters with histologic type ,2022
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy ,2023
Reports
Yetişkin Primer Prostat Sarkomu: Çok Merkezli Kohort Çalışma - Kara Burak Yavuz, ÖNEM KADİR, AÇIKGÖZ ABDULLAH, Şengül Mesut, ÇETİNKAYA MEHMET, ÇOBAN SONER, Topuz Bahadır, Kutsal Cemil, KOCA ORHAN, COŞKUN BURHAN, AYTAÇ VURUŞKAN BERNA, OKUMUŞ İBRAHİM BARIŞ, ERDEM DİLEK, Özkaya Muharrem
Patient and treatment characteristics in HR+/HER2-metastatic breast cancer in a real-life setting - KARADURMUŞ NURİ, ŞENDUR MEHMET ALİ NAHİT, ÇİL TİMUÇİN, ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA, ARSLAN ÇAĞATAY, HARPUTLUOĞLU HAKAN, SEZGİN GÖKSU SEMA, ÖZTÜRK BANU, İNANÇ MEVLÜDE, ÇUBUKÇU ERDEM, DEMİRCİ UMUT, ERDEM DİLEK, CİHAN ŞENER, TURAL DENİZ, DUMLUDAĞ AYŞEGÜL, AYKAN MUSA BARIŞ, YILMAZ FUNDA, AVŞAR ESİN, DİNÇ SONUŞEN SERMİN, ÖZTÜRK ÖZGE FULYA ÖZTÜRK, AVER BİRKAN, KAPLAN MUHAMMED ALİ
Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study). - BİLİCİ AHMET, ÖLMEZ ÖMER FATİH, SEZER AHMET, ÇAKMAK ÖKSÜZOĞLU ÖMÜR BERNA, KAPLAN MUHAMMED ALİ, KARADURMUŞ NURİ, ÇUBUKÇU ERDEM, ŞENDUR MEHMET ALİ NAHİT, AKSOY SERCAN, ERDEM DİLEK, BAŞARAN GÜL, ÇAKAR BURCU, ŞEKER MESUT, ARSLAN ÇAĞATAY, SEZGİN GÖKSU SEMA, ÇİÇİN İRFAN, GÜMÜŞ MAHMUT, SELÇUKBİRİCİK FATİH, HARPUTLUOĞLU HAKAN, HELVACI KAAN
Comparison of objective response rate and long-term overall survival in patients with
treated immune checkpoint inhibitors in metastatic urothelial carcinoma. - TURAL DENİZ, ARSLAN ÇAĞATAY, SELÇUKBİRİCİK FATİH, ÖLMEZ ÖMER FATİH, AKAR EMRE, ERMAN MUSTAFA, ÜRÜN YÜKSEL, ERDEM DİLEK, KILIÇKAP SAADETTİN
Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey - ŞENDUR MEHMET ALİ NAHİT, ÇAKAR BURCU, HIZAL MUTLU, ERASLAN EMRAH, AKSOY SERCAN, PAYDAŞ SEMRA, Demir Necla, ŞEN FATMA, BULUT GÜLCAN, ORUÇ KEREM, OYAN ULUÇ BAŞAK, ÖZDEMİR NURİYE, SAKİN ABDULLAH, ERDEM DİLEK, ÖZKAN METİN, DİŞEL UMUT, EKİNCİ FERHAT, Ökten İlker Nihat, ÖZER LEYLA, GÖKMEN ERHAN
Books
TORAKS TÜMÖRLERİ – AKADEMİSYEN YAYINEVİ
KANSER KEMOTERAPİ EL KİTABI – NOBEL TIP KİTABEVİ
KANSER KEMOTERAPİ EL KİTABI – NOBEL TIP KİTABEVİ
Türkiye Klinikleri Tıbbi Onkoloji - Özel Konular İmmünoonkoloji ve İmmünoonkolojik Tedaviler – Türkiye Klinikleri
Türkiye Klinikleri Tıbbi Onkoloji - Özel KonularProstat Kanseri Özel Sayısı – Türkiye Klinikleri
